Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (381-390 of 659) with videos related to

Pageof 66
Sort By:
Blood Advances|August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapseBachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
British Journal of Haematology|May 9, 2024
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous diseaseWei-Ying Jen, Hagop Kantarjian, Tapan M Kadia, et al.
Virology|May 22, 2003
A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropismKoichi Takayama, Paul N Reynolds, Joshua J Short, et al.
Blood Advances|September 30, 2021
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemiaDavid McCall, Michael Roth, Kris M Mahadeo, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 2007
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorderRobert L Findling, Elizabeth J Short, Nora K McNamara, et al.
Cancer|May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phaseFadi G Haddad, Koji Sasaki, Lewis Nasr, et al.
Cancer|October 31, 2009
Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for interventionLouise J Short, Maxine D Fisher, Peter M Wahl, et al.
Nature Neuroscience|February 8, 2006
Altering expectancy dampens neural response to aversive taste in primary taste cortexJack B Nitschke, Gregory E Dixon, Issidoros Sarinopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 13, 2025
Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18)Diane Habib, Elias Jabbour, Alex Bataller, et al.
Blood Advances|February 24, 2022
Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside-based low-intensity therapySangeetha Venugopal, Gautam Borthakur, Naval Daver, et al.
Pageof 66

Showing results (381-390 of 659) with videos related to

Sort By:
Pageof 66
Blood Advances|August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapseBachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
British Journal of Haematology|May 9, 2024
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous diseaseWei-Ying Jen, Hagop Kantarjian, Tapan M Kadia, et al.
Virology|May 22, 2003
A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropismKoichi Takayama, Paul N Reynolds, Joshua J Short, et al.
Blood Advances|September 30, 2021
Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemiaDavid McCall, Michael Roth, Kris M Mahadeo, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 1, 2007
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorderRobert L Findling, Elizabeth J Short, Nora K McNamara, et al.
Cancer|May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phaseFadi G Haddad, Koji Sasaki, Lewis Nasr, et al.
Cancer|October 31, 2009
Disparities in medical care among commercially insured patients with newly diagnosed breast cancer: opportunities for interventionLouise J Short, Maxine D Fisher, Peter M Wahl, et al.
Nature Neuroscience|February 8, 2006
Altering expectancy dampens neural response to aversive taste in primary taste cortexJack B Nitschke, Gregory E Dixon, Issidoros Sarinopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 13, 2025
Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18)Diane Habib, Elias Jabbour, Alex Bataller, et al.
Blood Advances|February 24, 2022
Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside-based low-intensity therapySangeetha Venugopal, Gautam Borthakur, Naval Daver, et al.
Pageof 66